Biomotion Sciences Ordinary Shares
SLXN
FAIR PRICE VALUATION
Updated daily
Model: DCF 50% · Relative 30% · Consensus 20%
MARKET PRICE
$1.27
FAIR PRICE
$1.81
MARGIN
$0.54
P/E Ratio
0.2x
Div. Yield
N/A
ROE
-649.6%
Market Cap
$684376
Small-cap
COMING SOON
Get notified when SLXN's fair price changes
Fair Price Index app is launching soon with push notifications when valuations shift for stocks you follow.
iOS and Android · Free tier available
KEY FACTS
CEO
Ilan Hadar
COUNTRY
IL
HEADQUARTERS
Jerusalem
SECTOR
Healthcare
EXCHANGE
NASDAQ
METHODOLOGY
How we calculate SLXN's fair price
Biomotion Sciences Ordinary Shares's fair price of $1.81 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%). At the current market price of $1.27, SLXN trades 42.5% below its calculated fair value. The stock's P/E of 0.2x is a key input in the relative valuation component.
DCF MODEL · 50%
Discounted cash flow analysis based on projected free cash flows, discounted at a rate reflecting SLXN's risk profile.
RELATIVE · 30%
Comparing SLXN's valuation multiples against Healthcare peers.
ANALYST · 20%
Aggregated analyst price targets for SLXN, weighted by recency and analyst accuracy.
POWERED BY BULIOS
Get full analysis, financials, and AI insights for SLXN.
Explore on BuliosFAQ
What is the fair price of SLXN?+
Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Biomotion Sciences Ordinary Shares is $1.81. At the current market price of $1.27, SLXN trades 42.5% below its calculated fair value.
Is SLXN overvalued or undervalued?+
Biomotion Sciences Ordinary Shares is currently undervalued based on our valuation model. The stock trades at $1.27, which is 42.5% below the fair price of $1.81. The P/E ratio of 0.2x is a key metric in the valuation.
How often is SLXN's fair price updated?+
We update fair price calculations for SLXN daily after market close. The current fair price of $1.81 incorporates the latest market data and sector multiples.
What factors affect SLXN's fair price calculation?+
SLXN's fair price of $1.81 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 0.2x, ROE of -649.6%.
Is SLXN a good buy right now?+
At $1.27, SLXN trades 42.5% below our fair value estimate of $1.81. The stock is currently undervalued. ROE stands at -649.6% (average). Fair Price Index provides valuation data — always do your own research before investing.
Does SLXN pay dividends?+
SLXN does not currently pay a dividend.